Full Text View
Tabular View
No Study Results Posted
Related Studies
A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury
This study has been completed.
Study NCT00557973   Information provided by XenoPort, Inc.

First Received on November 12, 2007.   Last Updated on September 10, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Muscle Spasticity
Additional conditions recognized in this trial
Spinal Cord Injuries
More general conditions related to this trial
Central Nervous System Diseases
Muscle Hypertonia
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Manifestations
Signs and Symptoms
Spinal Cord Diseases
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
XP19986, 10 mg BID
XP19986, 20 mg BID
XP19986, 30 mg BID
Sponsors listed in this trial
XenoPort, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services